We're sunsetting PodQuest on 2025-07-28. Thank you for your support!
Export Podcast Subscriptions
back
#22 - Tom Dayspring, M.D., FACP, FNLA – Part III of V: HDL, reverse cholesterol transport, CETP inhibitors, and apolipoproteins
01:04:13
Share
2018/10/17
The Peter Attia Drive
AI Chapters
Transcribe
Chapters
What is reverse cholesterol transport?
Understanding lipid transportation and apolipoproteins
The role of remnant lipoproteins and apoC-III
Particles having sex: lipid exchange
Exploring Cholesteryl Ester Transfer Protein (CETP) and CETP inhibitors
The 2006 CETP inhibitor trial: torcetrapib by Pfizer
The 2012 CETP inhibitor trial: dalcetrapib by Hoffmann–La Roche
The 2017 CETP inhibitor trials: evacetrapib and anacetrapib
Shownotes
Transcript
No transcript made for this episode yet, you may request it for free.